Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Depression × Venlafaxine Hydrochloride × Clear all

Phase

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 2 Depressive Disorder 1 Depression 1

Interventions

Psychiatric Rehabilitation 2 Ketamine 2 Venlafaxine Hydrochloride 1 Therapeutics 1 Holistic Health 1 Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05724849 2024-01-18

Venlafaxine for the Prevention of Depression in Patients With Head and Neck Cancer

Vanderbilt University Medical Center

Phase 2 Withdrawn

Depression, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡